Abstract
Mutations in LRRK2 are a common cause of genetic Parkinson's disease (PD). LRRK2 is a multi-domain Roco protein, harbouring kinase and GTPase activity. In analogy with a bacterial homologue, LRRK2 was proposed to act as a GTPase activated by dimerization (GAD), while recent reports suggest LRRK2 to exist under a monomeric and dimeric form in vivo. It is however unknown how LRRK2 oligomerization is regulated. Here, we show that oligomerization of a homologous bacterial Roco protein depends on the nucleotide load. The protein is mainly dimeric in the nucleotide-free and GDP-bound states, while it forms monomers upon GTP binding, leading to a monomer-dimer cycle during GTP hydrolysis. An analogue of a PD-associated mutation stabilizes the dimer and decreases the GTPase activity. This work thus provides insights into the conformational cycle of Roco proteins and suggests a link between oligomerization and disease-associated mutations in LRRK2.
Original language | English |
---|---|
Article number | 1008 |
Pages (from-to) | 1-12 |
Number of pages | 12 |
Journal | Nature Communications |
Volume | 8 |
Issue number | 1 |
DOIs | |
Publication status | Published - 18-Oct-2017 |
Keywords
- Parkinson's disease
- LRRK2
- protein conformation
- transition
- GTP-binding
Fingerprint
Dive into the research topics of 'A homologue of the Parkinson's disease-associated protein LRRK2 undergoes a monomer-dimer transition during GTP turnover'. Together they form a unique fingerprint.Press/Media
-
Proces in Parkinson-eiwit wellicht toekomstige therapeutische piste
18/10/2017
1 Media contribution
Press/Media: Public Engagement Activities › Popular
-
Newly described process in Parkinson’s protein as a potential new therapy route
18/10/2017
1 Media contribution
Press/Media: Public Engagement Activities › Popular
-
Proces in Parkinson-eiwit als toekomstige therapeutische piste
18/10/2017
1 Media contribution
Press/Media: Public Engagement Activities › Popular